Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of clinical studies evaluating platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs).
MIBO PRP checklist (PDF)
MIBO stem cells checklist (PDF)
|Full bibliographic reference||Murray IR, Geeslin AG, Goudie EB, Petrigliano FA, LaPrade RF. Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): Platelet-Rich Plasma and Mesenchymal Stem Cells. J Bone Joint Surg Am. 2017;99(10):809-819.|
|Reporting guideline website URL||https://www.mibo-statement.org/|
|Reporting guideline acronym||MIBO|
|Study design||Clinical trials, Experimental studies, Observational studies, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews|
|Clinical area||Rheumatology, Sport and exercise medicine, Surgery|
|Applies to the whole report or to individual sections of the report?||Ethical issues (consent etc.), Harms/adverse effects/safety data, Intervention (exposure), Outcomes (variables), Procedure/Method, Study characteristics (participants etc.)|
|Additional information||Murray IR, Murray AD, Geeslin AG, Goudie EB, White TO, Petrigliano FA, LaPrade RF. Infographic: we need minimum reporting standards for biologics. Br J Sports Med. 2017. PMID: 28831016|
|Record last updated on||November 25, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.